1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 17 NOVEMBER 2014

CNS Drug News 17 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - FDA Approval Will See Lemtrada Become A Blockbuster
Industry Brief - Impax Submits MAA For IPX066
Industry Brief - NeuroDerm Reports Positive Top-Line Phase II Results In Moderate-To-Severe PD
Industry Brief - Anavex Receives Regulatory Approval To Initiate Phase IIa Trial In AD
Industry Brief - GliaCure's AD Product Candidate Receives FDA Fast Track Designation
Industry Brief - FDA Grants ODD To Auspex' SD-809 For HD
Industry Brief - MTP Files Application For Additional Indication Of Radicut In ALS
Industry Brief - D-Pharm Reports First Results From THR-18 Phase II Study In tPA-Treated AIS Patients
Industry Brief - FDA Approves sNDAs For Invega Sustenna For Schizoaffective Disorder
Industry Brief - FDA Accepts Actavis' Saphris sNDA For BPID In Paediatric Patients
Industry Brief - Breckenridge Reports Quetiapine Approval In US
Industry Brief - Highland Reports Positive Top-Line Data From Phase III Trial In Paediatric ADHD
Industry Brief - Transition Reports Findings From BPD Phase II Study
Industry Brief - Pain Therapeutics To Regain Full Rights To Remoxy From Pfizer
Industry Trend Analysis - Avanir's Inhaled Migraine Therapy Will Not Be FDA-Approved In November
Industry Brief - Pernix Submits sNDA For Treximet Use In Adolescent Patients
Industry Brief - Ono To Not File Remimazolam In Japan; To Return Rights To PAION
Industry Trend Analysis - Smoking Cessation: A Blockbuster Opportunity For Belviq
Industry Trend Analysis - Eisai's Fycompa Will Remain Off German Market
Industry Brief - Fourth US Patent Protecting Trokendi XR Issued
Industry Brief - Eisai's Zonegran Approved In Russia For Children/Adolescents
Industry Brief - Fycompa Receives Reimbursement In Australia
Industry Brief - SAGE Reports Positive Top-Line Phase II Data In SRSE
Industry Brief - NeuroSearch Signs Agreement To Transfer Phase I-II Projects
Industry Brief - ICT/Takeda To Terminate Collaboration On PDE1 Inhibitors For CNS Disorders
Industry Trend Analysis - Neuren Targets Growing Orphan Drug Market
Industry Brief - Eisai Neuroscience Business Officially Launched In Belgium And Luxembourg
Industry Brief - CNS Conferences - February 2015

Table Of Contents

CNS Drug News 17 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.